Medical Care
Global Transcriptomics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jul 08, 25
- ID: 353243
- Pages: 124
- Figures: 125
- Views: 14
In 2024, the global market size of Transcriptomics was estimated to be worth US$ 4561 million and is forecast to reach approximately US$ 8808 million by 2031 with a CAGR of 10.0% during the forecast period 2025-2031.
Transcriptomic incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics. The global transcriptomic market could see a whole lot of instances of new product launch. For example, Trio RNA-Seq launched by NuGEN Technologies, Inc. is particularly suited for low abundance transcripts applications as it offers an extremely sensitive whole transcriptomic solution. This innovation embodies three powerful technologies, viz. single primer isothermal amplification (SPIA), DimerFree, and AnyDeplete, for performing high sensitivity ribonucleic acid (RNA) analysis.
North America is the largest consumption place, with a consumption market share nearly 55% . Following North America, Europe is the second largest consumption place with the consumption market share of 25% .The key manufacturers are Thermo Fisher Scientific, Illumina, QIAGEN (Exiqon), Agilent Technologies, Roche, GE Healthcare, Bio-Rad Laboratories, Fluidigm etc. Top 3 companies occupied about 41% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Transcriptomics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transcriptomics.
The Transcriptomics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Transcriptomics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transcriptomics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm
Segment by Type
PCR
Microarray
Sequencing
Segment by Application
Pharmaceutical and Biotechnology
Academic Research and Government Institutes
Hospitals and Diagnostic Centers
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Transcriptomics in global and regional level.
Chapter 3: Detailed analysis of Transcriptomics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Transcriptomics revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Transcriptomic incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics. The global transcriptomic market could see a whole lot of instances of new product launch. For example, Trio RNA-Seq launched by NuGEN Technologies, Inc. is particularly suited for low abundance transcripts applications as it offers an extremely sensitive whole transcriptomic solution. This innovation embodies three powerful technologies, viz. single primer isothermal amplification (SPIA), DimerFree, and AnyDeplete, for performing high sensitivity ribonucleic acid (RNA) analysis.
North America is the largest consumption place, with a consumption market share nearly 55% . Following North America, Europe is the second largest consumption place with the consumption market share of 25% .The key manufacturers are Thermo Fisher Scientific, Illumina, QIAGEN (Exiqon), Agilent Technologies, Roche, GE Healthcare, Bio-Rad Laboratories, Fluidigm etc. Top 3 companies occupied about 41% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Transcriptomics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transcriptomics.
The Transcriptomics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Transcriptomics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transcriptomics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm
Segment by Type
PCR
Microarray
Sequencing
Segment by Application
Pharmaceutical and Biotechnology
Academic Research and Government Institutes
Hospitals and Diagnostic Centers
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Transcriptomics in global and regional level.
Chapter 3: Detailed analysis of Transcriptomics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Transcriptomics revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
1 Study Coverage
1.1 Transcriptomics Product Introduction
1.2 Market by Type
1.2.1 Global Transcriptomics Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 PCR
1.2.3 Microarray
1.2.4 Sequencing
1.3 Market by Application
1.3.1 Global Transcriptomics Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Pharmaceutical and Biotechnology
1.3.3 Academic Research and Government Institutes
1.3.4 Hospitals and Diagnostic Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Transcriptomics Market Size Estimates and Forecasts
2.2 Transcriptomics Market Size by Region: 2024 Versus 2031
2.2.1 Global Transcriptomics Revenue by Region: 2020-2025
2.2.2 Global Transcriptomics Revenue Forecast by Region (2026-2031)
2.2.3 Global Transcriptomics Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Transcriptomics Revenue by Type (2020-2031)
3.1.2 Global Transcriptomics Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Transcriptomics Revenue by Application (2020-2031)
3.2.2 Global Transcriptomics Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 PCR of Transcriptomics Revenue Market Share by Application
3.3.2 Microarray of Transcriptomics Revenue Market Share by Application
3.3.3 Sequencing of Transcriptomics Revenue Market Share by Application
4 Global Transcriptomics by Company
4.1 Global Transcriptomics Revenue by Company (2020-2025)
4.2 Global Transcriptomics Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Transcriptomics Companies around the World: Ranking by Revenue
4.3.2 Global Transcriptomics Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Transcriptomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Transcriptomics Companies Headquarters & Product Type
4.4.1 Global Transcriptomics Companies Headquarters
4.4.2 Date of International Companies Enter into Transcriptomics Market
4.4.3 Global Transcriptomics Companies Product & Service
4.4.4 PCR Revenue Market Share of Transcriptomics by Company
4.4.5 Microarray Revenue Market Share of Transcriptomics by Company
4.4.6 Sequencing Revenue Market Share of Transcriptomics by Company
4.5 Global Transcriptomics Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Thermo Fisher Scientific
5.1.1 Thermo Fisher Scientific Corporation Information
5.1.2 Thermo Fisher Scientific Description, Business Overview
5.1.3 Thermo Fisher Scientific Transcriptomics Products Offered
5.1.4 Thermo Fisher Scientific Transcriptomics Revenue and Gross Margin (2020-2025)
5.1.5 Thermo Fisher Scientific Transcriptomics Revenue by Product in 2024
5.1.6 Thermo Fisher Scientific Transcriptomics Revenue by Application in 2024
5.1.7 Thermo Fisher Scientific Transcriptomics Revenue by Geographic Area in 2024
5.1.8 Thermo Fisher Scientific Recent Developments
5.2 Illumina
5.2.1 Illumina Corporation Information
5.2.2 Illumina Description, Business Overview
5.2.3 Illumina Transcriptomics Products Offered
5.2.4 Illumina Transcriptomics Revenue and Gross Margin (2020-2025)
5.2.5 Illumina Transcriptomics Revenue by Product in 2024
5.2.6 Illumina Transcriptomics Revenue by Application in 2024
5.2.7 Illumina Transcriptomics Revenue by Geographic Area in 2024
5.2.8 Illumina Recent Developments
5.3 QIAGEN (Exiqon)
5.3.1 QIAGEN (Exiqon) Corporation Information
5.3.2 QIAGEN (Exiqon) Description, Business Overview
5.3.3 QIAGEN (Exiqon) Transcriptomics Products Offered
5.3.4 QIAGEN (Exiqon) Transcriptomics Revenue and Gross Margin (2020-2025)
5.3.5 QIAGEN (Exiqon) Transcriptomics Revenue by Product in 2024
5.3.6 QIAGEN (Exiqon) Transcriptomics Revenue by Application in 2024
5.3.7 QIAGEN (Exiqon) Transcriptomics Revenue by Geographic Area in 2024
5.3.8 QIAGEN (Exiqon) Recent Developments
5.4 Agilent Technologies
5.4.1 Agilent Technologies Corporation Information
5.4.2 Agilent Technologies Description, Business Overview
5.4.3 Agilent Technologies Transcriptomics Products Offered
5.4.4 Agilent Technologies Transcriptomics Revenue and Gross Margin (2020-2025)
5.4.5 Agilent Technologies Transcriptomics Revenue by Product in 2024
5.4.6 Agilent Technologies Transcriptomics Revenue by Application in 2024
5.4.7 Agilent Technologies Transcriptomics Revenue by Geographic Area in 2024
5.4.8 Agilent Technologies Recent Developments
5.5 Roche
5.5.1 Roche Corporation Information
5.5.2 Roche Description, Business Overview
5.5.3 Roche Transcriptomics Products Offered
5.5.4 Roche Transcriptomics Revenue and Gross Margin (2020-2025)
5.5.5 Roche Transcriptomics Revenue by Product in 2024
5.5.6 Roche Transcriptomics Revenue by Application in 2024
5.5.7 Roche Transcriptomics Revenue by Geographic Area in 2024
5.5.8 Roche Recent Developments
5.6 GE Healthcare
5.6.1 GE Healthcare Corporation Information
5.6.2 GE Healthcare Description, Business Overview
5.6.3 GE Healthcare Transcriptomics Products Offered
5.6.4 GE Healthcare Transcriptomics Revenue and Gross Margin (2020-2025)
5.6.5 GE Healthcare Transcriptomics Revenue by Product in 2024
5.6.6 GE Healthcare Transcriptomics Revenue by Application in 2024
5.6.7 GE Healthcare Transcriptomics Revenue by Geographic Area in 2024
5.6.8 GE Healthcare Recent Developments
5.7 Bio-Rad Laboratories
5.7.1 Bio-Rad Laboratories Corporation Information
5.7.2 Bio-Rad Laboratories Description, Business Overview
5.7.3 Bio-Rad Laboratories Transcriptomics Products Offered
5.7.4 Bio-Rad Laboratories Transcriptomics Revenue and Gross Margin (2020-2025)
5.7.5 Bio-Rad Laboratories Transcriptomics Revenue by Product in 2024
5.7.6 Bio-Rad Laboratories Transcriptomics Revenue by Application in 2024
5.7.7 Bio-Rad Laboratories Transcriptomics Revenue by Geographic Area in 2024
5.7.8 Bio-Rad Laboratories Recent Developments
5.8 Fluidigm
5.8.1 Fluidigm Corporation Information
5.8.2 Fluidigm Description, Business Overview
5.8.3 Fluidigm Transcriptomics Products Offered
5.8.4 Fluidigm Transcriptomics Revenue and Gross Margin (2020-2025)
5.8.5 Fluidigm Transcriptomics Revenue by Product in 2024
5.8.6 Fluidigm Transcriptomics Revenue by Application in 2024
5.8.7 Fluidigm Transcriptomics Revenue by Geographic Area in 2024
5.8.8 Fluidigm Recent Developments
6 North America
6.1 North America Transcriptomics Market Size YoY Growth 2020-2031
6.2 North America Transcriptomics Market Facts & Figures by Country (2020-2031)
6.3 North America Transcriptomics Revenue by Type (2020-2025)
6.4 North America Transcriptomics Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Transcriptomics Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Transcriptomics Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Transcriptomics Revenue by Type (2020-2025)
7.4 Asia-Pacific Transcriptomics Revenue by Application (2020-2025)
8 Europe
8.1 Europe Transcriptomics Market Size YoY Growth 2020-2031
8.2 Europe Transcriptomics Market Facts & Figures by Country (2020-2031)
8.3 Europe Transcriptomics Revenue by Type (2020-2025)
8.4 Europe Transcriptomics Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Transcriptomics Market Size YoY Growth 2020-2031
9.2 Latin America Transcriptomics Market Facts & Figures by Country (2020-2031)
9.3 Latin America Transcriptomics Revenue by Type (2020-2025)
9.4 Latin America Transcriptomics Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Transcriptomics Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Transcriptomics Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Transcriptomics Revenue by Type (2020-2025)
10.4 Middle East and Africa Transcriptomics Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Transcriptomics Supply Chain Analysis
11.2 Transcriptomics Key Raw Materials and Upstream Suppliers
11.3 Transcriptomics Clients Analysis
11.4 Transcriptomics Sales Channel and Sales Model Analysis
11.4.1 Transcriptomics Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Transcriptomics Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Transcriptomics Distributors
12 Transcriptomics Market Dynamics
12.1 Transcriptomics Industry Trends
12.2 Transcriptomics Market Drivers
12.3 Transcriptomics Market Challenges
12.4 Transcriptomics Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Transcriptomics Product Introduction
1.2 Market by Type
1.2.1 Global Transcriptomics Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 PCR
1.2.3 Microarray
1.2.4 Sequencing
1.3 Market by Application
1.3.1 Global Transcriptomics Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Pharmaceutical and Biotechnology
1.3.3 Academic Research and Government Institutes
1.3.4 Hospitals and Diagnostic Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Transcriptomics Market Size Estimates and Forecasts
2.2 Transcriptomics Market Size by Region: 2024 Versus 2031
2.2.1 Global Transcriptomics Revenue by Region: 2020-2025
2.2.2 Global Transcriptomics Revenue Forecast by Region (2026-2031)
2.2.3 Global Transcriptomics Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Transcriptomics Revenue by Type (2020-2031)
3.1.2 Global Transcriptomics Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Transcriptomics Revenue by Application (2020-2031)
3.2.2 Global Transcriptomics Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 PCR of Transcriptomics Revenue Market Share by Application
3.3.2 Microarray of Transcriptomics Revenue Market Share by Application
3.3.3 Sequencing of Transcriptomics Revenue Market Share by Application
4 Global Transcriptomics by Company
4.1 Global Transcriptomics Revenue by Company (2020-2025)
4.2 Global Transcriptomics Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Transcriptomics Companies around the World: Ranking by Revenue
4.3.2 Global Transcriptomics Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Transcriptomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Transcriptomics Companies Headquarters & Product Type
4.4.1 Global Transcriptomics Companies Headquarters
4.4.2 Date of International Companies Enter into Transcriptomics Market
4.4.3 Global Transcriptomics Companies Product & Service
4.4.4 PCR Revenue Market Share of Transcriptomics by Company
4.4.5 Microarray Revenue Market Share of Transcriptomics by Company
4.4.6 Sequencing Revenue Market Share of Transcriptomics by Company
4.5 Global Transcriptomics Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Thermo Fisher Scientific
5.1.1 Thermo Fisher Scientific Corporation Information
5.1.2 Thermo Fisher Scientific Description, Business Overview
5.1.3 Thermo Fisher Scientific Transcriptomics Products Offered
5.1.4 Thermo Fisher Scientific Transcriptomics Revenue and Gross Margin (2020-2025)
5.1.5 Thermo Fisher Scientific Transcriptomics Revenue by Product in 2024
5.1.6 Thermo Fisher Scientific Transcriptomics Revenue by Application in 2024
5.1.7 Thermo Fisher Scientific Transcriptomics Revenue by Geographic Area in 2024
5.1.8 Thermo Fisher Scientific Recent Developments
5.2 Illumina
5.2.1 Illumina Corporation Information
5.2.2 Illumina Description, Business Overview
5.2.3 Illumina Transcriptomics Products Offered
5.2.4 Illumina Transcriptomics Revenue and Gross Margin (2020-2025)
5.2.5 Illumina Transcriptomics Revenue by Product in 2024
5.2.6 Illumina Transcriptomics Revenue by Application in 2024
5.2.7 Illumina Transcriptomics Revenue by Geographic Area in 2024
5.2.8 Illumina Recent Developments
5.3 QIAGEN (Exiqon)
5.3.1 QIAGEN (Exiqon) Corporation Information
5.3.2 QIAGEN (Exiqon) Description, Business Overview
5.3.3 QIAGEN (Exiqon) Transcriptomics Products Offered
5.3.4 QIAGEN (Exiqon) Transcriptomics Revenue and Gross Margin (2020-2025)
5.3.5 QIAGEN (Exiqon) Transcriptomics Revenue by Product in 2024
5.3.6 QIAGEN (Exiqon) Transcriptomics Revenue by Application in 2024
5.3.7 QIAGEN (Exiqon) Transcriptomics Revenue by Geographic Area in 2024
5.3.8 QIAGEN (Exiqon) Recent Developments
5.4 Agilent Technologies
5.4.1 Agilent Technologies Corporation Information
5.4.2 Agilent Technologies Description, Business Overview
5.4.3 Agilent Technologies Transcriptomics Products Offered
5.4.4 Agilent Technologies Transcriptomics Revenue and Gross Margin (2020-2025)
5.4.5 Agilent Technologies Transcriptomics Revenue by Product in 2024
5.4.6 Agilent Technologies Transcriptomics Revenue by Application in 2024
5.4.7 Agilent Technologies Transcriptomics Revenue by Geographic Area in 2024
5.4.8 Agilent Technologies Recent Developments
5.5 Roche
5.5.1 Roche Corporation Information
5.5.2 Roche Description, Business Overview
5.5.3 Roche Transcriptomics Products Offered
5.5.4 Roche Transcriptomics Revenue and Gross Margin (2020-2025)
5.5.5 Roche Transcriptomics Revenue by Product in 2024
5.5.6 Roche Transcriptomics Revenue by Application in 2024
5.5.7 Roche Transcriptomics Revenue by Geographic Area in 2024
5.5.8 Roche Recent Developments
5.6 GE Healthcare
5.6.1 GE Healthcare Corporation Information
5.6.2 GE Healthcare Description, Business Overview
5.6.3 GE Healthcare Transcriptomics Products Offered
5.6.4 GE Healthcare Transcriptomics Revenue and Gross Margin (2020-2025)
5.6.5 GE Healthcare Transcriptomics Revenue by Product in 2024
5.6.6 GE Healthcare Transcriptomics Revenue by Application in 2024
5.6.7 GE Healthcare Transcriptomics Revenue by Geographic Area in 2024
5.6.8 GE Healthcare Recent Developments
5.7 Bio-Rad Laboratories
5.7.1 Bio-Rad Laboratories Corporation Information
5.7.2 Bio-Rad Laboratories Description, Business Overview
5.7.3 Bio-Rad Laboratories Transcriptomics Products Offered
5.7.4 Bio-Rad Laboratories Transcriptomics Revenue and Gross Margin (2020-2025)
5.7.5 Bio-Rad Laboratories Transcriptomics Revenue by Product in 2024
5.7.6 Bio-Rad Laboratories Transcriptomics Revenue by Application in 2024
5.7.7 Bio-Rad Laboratories Transcriptomics Revenue by Geographic Area in 2024
5.7.8 Bio-Rad Laboratories Recent Developments
5.8 Fluidigm
5.8.1 Fluidigm Corporation Information
5.8.2 Fluidigm Description, Business Overview
5.8.3 Fluidigm Transcriptomics Products Offered
5.8.4 Fluidigm Transcriptomics Revenue and Gross Margin (2020-2025)
5.8.5 Fluidigm Transcriptomics Revenue by Product in 2024
5.8.6 Fluidigm Transcriptomics Revenue by Application in 2024
5.8.7 Fluidigm Transcriptomics Revenue by Geographic Area in 2024
5.8.8 Fluidigm Recent Developments
6 North America
6.1 North America Transcriptomics Market Size YoY Growth 2020-2031
6.2 North America Transcriptomics Market Facts & Figures by Country (2020-2031)
6.3 North America Transcriptomics Revenue by Type (2020-2025)
6.4 North America Transcriptomics Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Transcriptomics Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Transcriptomics Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Transcriptomics Revenue by Type (2020-2025)
7.4 Asia-Pacific Transcriptomics Revenue by Application (2020-2025)
8 Europe
8.1 Europe Transcriptomics Market Size YoY Growth 2020-2031
8.2 Europe Transcriptomics Market Facts & Figures by Country (2020-2031)
8.3 Europe Transcriptomics Revenue by Type (2020-2025)
8.4 Europe Transcriptomics Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Transcriptomics Market Size YoY Growth 2020-2031
9.2 Latin America Transcriptomics Market Facts & Figures by Country (2020-2031)
9.3 Latin America Transcriptomics Revenue by Type (2020-2025)
9.4 Latin America Transcriptomics Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Transcriptomics Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Transcriptomics Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Transcriptomics Revenue by Type (2020-2025)
10.4 Middle East and Africa Transcriptomics Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Transcriptomics Supply Chain Analysis
11.2 Transcriptomics Key Raw Materials and Upstream Suppliers
11.3 Transcriptomics Clients Analysis
11.4 Transcriptomics Sales Channel and Sales Model Analysis
11.4.1 Transcriptomics Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Transcriptomics Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Transcriptomics Distributors
12 Transcriptomics Market Dynamics
12.1 Transcriptomics Industry Trends
12.2 Transcriptomics Market Drivers
12.3 Transcriptomics Market Challenges
12.4 Transcriptomics Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Transcriptomics Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Transcriptomics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Transcriptomics Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Transcriptomics Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Transcriptomics Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Transcriptomics Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Transcriptomics Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Transcriptomics Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Transcriptomics Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Transcriptomics Revenue by Company (2020-2025) & (US$ Million)
Table 11. Transcriptomics Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Transcriptomics Players by Revenue (US$ Million) in 2024
Table 13. Global Transcriptomics Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Transcriptomics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transcriptomics as of 2024)
Table 15. Global Transcriptomics Companies Headquarters
Table 16. Date of International Companies Enter into Transcriptomics Market
Table 17. Global Transcriptomics Companies Product & Service
Table 18. Global Transcriptomics Mergers & Acquisitions, Expansion Plans
Table 19. Thermo Fisher Scientific Corporation Information
Table 20. Thermo Fisher Scientific Description and Business Overview
Table 21. Thermo Fisher Scientific Transcriptomics Product
Table 22. Thermo Fisher Scientific Transcriptomics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Thermo Fisher Scientific Revenue Proportion of Transcriptomics by Product in 2024
Table 24. Thermo Fisher Scientific Revenue Proportion of Transcriptomics by Application in 2024
Table 25. Thermo Fisher Scientific Revenue Proportion of Transcriptomics by Geographic Area in 2024
Table 26. Thermo Fisher Scientific Recent Developments
Table 27. Illumina Corporation Information
Table 28. Illumina Description and Business Overview
Table 29. Illumina Transcriptomics Product
Table 30. Illumina Transcriptomics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Illumina Revenue Proportion of Transcriptomics by Product in 2024
Table 32. Illumina Revenue Proportion of Transcriptomics by Application in 2024
Table 33. Illumina Revenue Proportion of Transcriptomics by Geographic Area in 2024
Table 34. Illumina Recent Developments
Table 35. QIAGEN (Exiqon) Corporation Information
Table 36. QIAGEN (Exiqon) Description and Business Overview
Table 37. QIAGEN (Exiqon) Transcriptomics Product
Table 38. QIAGEN (Exiqon) Transcriptomics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. QIAGEN (Exiqon) Revenue Proportion of Transcriptomics by Product in 2024
Table 40. QIAGEN (Exiqon) Revenue Proportion of Transcriptomics by Application in 2024
Table 41. QIAGEN (Exiqon) Revenue Proportion of Transcriptomics by Geographic Area in 2024
Table 42. QIAGEN (Exiqon) Recent Developments
Table 43. Agilent Technologies Corporation Information
Table 44. Agilent Technologies Description and Business Overview
Table 45. Agilent Technologies Transcriptomics Product
Table 46. Agilent Technologies Transcriptomics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Agilent Technologies Revenue Proportion of Transcriptomics by Product in 2024
Table 48. Agilent Technologies Revenue Proportion of Transcriptomics by Application in 2024
Table 49. Agilent Technologies Revenue Proportion of Transcriptomics by Geographic Area in 2024
Table 50. Agilent Technologies Recent Developments
Table 51. Roche Corporation Information
Table 52. Roche Description and Business Overview
Table 53. Roche Transcriptomics Product
Table 54. Roche Transcriptomics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Roche Revenue Proportion of Transcriptomics by Product in 2024
Table 56. Roche Revenue Proportion of Transcriptomics by Application in 2024
Table 57. Roche Revenue Proportion of Transcriptomics by Geographic Area in 2024
Table 58. Roche Recent Developments
Table 59. GE Healthcare Corporation Information
Table 60. GE Healthcare Description and Business Overview
Table 61. GE Healthcare Transcriptomics Product
Table 62. GE Healthcare Transcriptomics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. GE Healthcare Revenue Proportion of Transcriptomics by Product in 2024
Table 64. GE Healthcare Revenue Proportion of Transcriptomics by Application in 2024
Table 65. GE Healthcare Revenue Proportion of Transcriptomics by Geographic Area in 2024
Table 66. GE Healthcare Recent Developments
Table 67. Bio-Rad Laboratories Corporation Information
Table 68. Bio-Rad Laboratories Description and Business Overview
Table 69. Bio-Rad Laboratories Transcriptomics Product
Table 70. Bio-Rad Laboratories Transcriptomics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Bio-Rad Laboratories Revenue Proportion of Transcriptomics by Product in 2024
Table 72. Bio-Rad Laboratories Revenue Proportion of Transcriptomics by Application in 2024
Table 73. Bio-Rad Laboratories Revenue Proportion of Transcriptomics by Geographic Area in 2024
Table 74. Bio-Rad Laboratories Recent Developments
Table 75. Fluidigm Corporation Information
Table 76. Fluidigm Description and Business Overview
Table 77. Fluidigm Transcriptomics Product
Table 78. Fluidigm Transcriptomics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Fluidigm Revenue Proportion of Transcriptomics by Product in 2024
Table 80. Fluidigm Revenue Proportion of Transcriptomics by Application in 2024
Table 81. Fluidigm Revenue Proportion of Transcriptomics by Geographic Area in 2024
Table 82. Fluidigm Recent Developments
Table 83. North America Transcriptomics Revenue by Country (2020-2025) & (US$ Million)
Table 84. North America Transcriptomics Revenue by Country (2026-2031) & (US$ Million)
Table 85. North America Transcriptomics Revenue by Type (2020-2025) & (US$ Million)
Table 86. North America Transcriptomics Revenue by Application (2020-2025) & (US$ Million)
Table 87. Asia-Pacific Transcriptomics Revenue by Region (2020-2025) & (US$ Million)
Table 88. Asia-Pacific Transcriptomics Revenue by Region (2026-2031) & (US$ Million)
Table 89. Asia-Pacific Transcriptomics Revenue by Type (2020-2025) & (US$ Million)
Table 90. Asia-Pacific Transcriptomics Revenue by Application (2020-2025) & (US$ Million)
Table 91. Europe Transcriptomics Revenue by Country (2020-2025) & (US$ Million)
Table 92. Europe Transcriptomics Revenue by Country (2026-2031) & (US$ Million)
Table 93. Europe Transcriptomics Revenue by Type (2020-2025) & (US$ Million)
Table 94. Europe Transcriptomics Revenue by Application (2020-2025) & (US$ Million)
Table 95. Latin America Transcriptomics Revenue by Country (2020-2025) & (US$ Million)
Table 96. Latin America Transcriptomics Revenue by Country (2026-2031) & (US$ Million)
Table 97. Latin America Transcriptomics Revenue by Type (2020-2025) & (US$ Million)
Table 98. Latin America Transcriptomics Revenue by Application (2020-2025) & (US$ Million)
Table 99. Middle East and Africa Transcriptomics Revenue by Country (2020-2025) & (US$ Million)
Table 100. Middle East and Africa Transcriptomics Revenue by Country (2026-2031) & (US$ Million)
Table 101. Middle East and Africa Transcriptomics Revenue by Type (2020-2025) & (US$ Million)
Table 102. Middle East and Africa Transcriptomics Revenue by Application (2020-2025) & (US$ Million)
Table 103. Transcriptomics Key Raw Materials, Industry Status and Trend
Table 104. Transcriptomics Key Raw Materials and Upstream Suppliers
Table 105. Transcriptomics Clients Status and Trend
Table 106. Transcriptomics Typical Clients
Table 107. Transcriptomics Distributors
Table 108. Transcriptomics Market Trends
Table 109. Transcriptomics Market Drivers
Table 110. Transcriptomics Market Challenges
Table 111. Transcriptomics Market Restraints
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Transcriptomics Product Picture
Figure 2. Global Transcriptomics Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Transcriptomics Revenue Market Share by Type in 2024 & 2031
Figure 4. PCR Product Picture
Figure 5. Microarray Product Picture
Figure 6. Sequencing Product Picture
Figure 7. Global Transcriptomics Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Transcriptomics Revenue Market Share by Application in 2024 & 2031
Figure 9. Pharmaceutical and Biotechnology
Figure 10. Academic Research and Government Institutes
Figure 11. Hospitals and Diagnostic Centers
Figure 12. Transcriptomics Report Years Considered
Figure 13. Global Transcriptomics Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Transcriptomics Market Size (2020-2031) & (US$ Million)
Figure 15. Global Transcriptomics Market Size Market Share by Region: 2024 Versus 2031
Figure 16. Global Transcriptomics Revenue Market Share by Region (2020-2031)
Figure 17. Global Transcriptomics Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Global Transcriptomics Revenue Market Share Forecast by Application (2020-2031)
Figure 19. PCR of Transcriptomics Revenue Market Share by Application, 2024 VS 2031
Figure 20. Microarray of Transcriptomics Revenue Market Share by Application, 2024 VS 2031
Figure 21. Sequencing of Transcriptomics Revenue Market Share by Application, 2024 VS 2031
Figure 22. Transcriptomics Revenue Share by Company (2024)
Figure 23. Transcriptomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. PCR Revenue Proportion by Company in 2024
Figure 25. Microarray Revenue Proportion by Company in 2024
Figure 26. Sequencing Revenue Proportion by Company in 2024
Figure 27. North America Transcriptomics Revenue 2020-2031 (US$ Million)
Figure 28. North America Transcriptomics Revenue Market Share by Type (2020-2025)
Figure 29. North America Transcriptomics Revenue Market Share by Application (2020-2025)
Figure 30. Asia-Pacific Transcriptomics Revenue 2020-2031 (US$ Million)
Figure 31. Asia-Pacific Transcriptomics Revenue Market Share by Region (2020-2031)
Figure 32. Asia-Pacific Transcriptomics Revenue Market Share by Type (2020-2025)
Figure 33. Asia-Pacific Transcriptomics Revenue Market Share by Application (2020-2025)
Figure 34. Europe Transcriptomics Revenue Growth Rate 2020-2031 (US$ Million)
Figure 35. Europe Transcriptomics Revenue Market Share by Country (2020-2031)
Figure 36. Europe Transcriptomics Revenue Market Share by Type (2020-2025)
Figure 37. Europe Transcriptomics Revenue Market Share by Application (2020-2025)
Figure 38. Latin America Transcriptomics Revenue Growth Rate 2020-2031 (US$ Million)
Figure 39. Latin America Transcriptomics Revenue Market Share by Country (2020-2031)
Figure 40. Latin America Transcriptomics Revenue Market Share by Type (2020-2025)
Figure 41. Latin America Transcriptomics Revenue Market Share by Application (2020-2025)
Figure 42. Middle East and Africa Transcriptomics Revenue Growth Rate 2020-2031 (US$ Million)
Figure 43. Middle East and Africa Transcriptomics Revenue Market Share by Country (2020-2031)
Figure 44. Middle East and Africa Transcriptomics Revenue Market Share by Type (2020-2025)
Figure 45. Middle East and Africa Transcriptomics Revenue Market Share by Application (2020-2025)
Figure 46. Transcriptomics Supply Chain (Upstream and Downstream Market)
Figure 47. Global Production Market Share of Transcriptomics Raw Materials by Region in 2024
Figure 48. Transcriptomics Distribution Channels
Figure 49. Global Transcriptomics Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 50. Global Transcriptomics Percentage 2020-2031: Online Sales VS Offline Sales
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Table 1. Global Transcriptomics Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Transcriptomics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Transcriptomics Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Transcriptomics Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Transcriptomics Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Transcriptomics Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Transcriptomics Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Transcriptomics Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Transcriptomics Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Transcriptomics Revenue by Company (2020-2025) & (US$ Million)
Table 11. Transcriptomics Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Transcriptomics Players by Revenue (US$ Million) in 2024
Table 13. Global Transcriptomics Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Transcriptomics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transcriptomics as of 2024)
Table 15. Global Transcriptomics Companies Headquarters
Table 16. Date of International Companies Enter into Transcriptomics Market
Table 17. Global Transcriptomics Companies Product & Service
Table 18. Global Transcriptomics Mergers & Acquisitions, Expansion Plans
Table 19. Thermo Fisher Scientific Corporation Information
Table 20. Thermo Fisher Scientific Description and Business Overview
Table 21. Thermo Fisher Scientific Transcriptomics Product
Table 22. Thermo Fisher Scientific Transcriptomics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Thermo Fisher Scientific Revenue Proportion of Transcriptomics by Product in 2024
Table 24. Thermo Fisher Scientific Revenue Proportion of Transcriptomics by Application in 2024
Table 25. Thermo Fisher Scientific Revenue Proportion of Transcriptomics by Geographic Area in 2024
Table 26. Thermo Fisher Scientific Recent Developments
Table 27. Illumina Corporation Information
Table 28. Illumina Description and Business Overview
Table 29. Illumina Transcriptomics Product
Table 30. Illumina Transcriptomics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Illumina Revenue Proportion of Transcriptomics by Product in 2024
Table 32. Illumina Revenue Proportion of Transcriptomics by Application in 2024
Table 33. Illumina Revenue Proportion of Transcriptomics by Geographic Area in 2024
Table 34. Illumina Recent Developments
Table 35. QIAGEN (Exiqon) Corporation Information
Table 36. QIAGEN (Exiqon) Description and Business Overview
Table 37. QIAGEN (Exiqon) Transcriptomics Product
Table 38. QIAGEN (Exiqon) Transcriptomics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. QIAGEN (Exiqon) Revenue Proportion of Transcriptomics by Product in 2024
Table 40. QIAGEN (Exiqon) Revenue Proportion of Transcriptomics by Application in 2024
Table 41. QIAGEN (Exiqon) Revenue Proportion of Transcriptomics by Geographic Area in 2024
Table 42. QIAGEN (Exiqon) Recent Developments
Table 43. Agilent Technologies Corporation Information
Table 44. Agilent Technologies Description and Business Overview
Table 45. Agilent Technologies Transcriptomics Product
Table 46. Agilent Technologies Transcriptomics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Agilent Technologies Revenue Proportion of Transcriptomics by Product in 2024
Table 48. Agilent Technologies Revenue Proportion of Transcriptomics by Application in 2024
Table 49. Agilent Technologies Revenue Proportion of Transcriptomics by Geographic Area in 2024
Table 50. Agilent Technologies Recent Developments
Table 51. Roche Corporation Information
Table 52. Roche Description and Business Overview
Table 53. Roche Transcriptomics Product
Table 54. Roche Transcriptomics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Roche Revenue Proportion of Transcriptomics by Product in 2024
Table 56. Roche Revenue Proportion of Transcriptomics by Application in 2024
Table 57. Roche Revenue Proportion of Transcriptomics by Geographic Area in 2024
Table 58. Roche Recent Developments
Table 59. GE Healthcare Corporation Information
Table 60. GE Healthcare Description and Business Overview
Table 61. GE Healthcare Transcriptomics Product
Table 62. GE Healthcare Transcriptomics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. GE Healthcare Revenue Proportion of Transcriptomics by Product in 2024
Table 64. GE Healthcare Revenue Proportion of Transcriptomics by Application in 2024
Table 65. GE Healthcare Revenue Proportion of Transcriptomics by Geographic Area in 2024
Table 66. GE Healthcare Recent Developments
Table 67. Bio-Rad Laboratories Corporation Information
Table 68. Bio-Rad Laboratories Description and Business Overview
Table 69. Bio-Rad Laboratories Transcriptomics Product
Table 70. Bio-Rad Laboratories Transcriptomics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Bio-Rad Laboratories Revenue Proportion of Transcriptomics by Product in 2024
Table 72. Bio-Rad Laboratories Revenue Proportion of Transcriptomics by Application in 2024
Table 73. Bio-Rad Laboratories Revenue Proportion of Transcriptomics by Geographic Area in 2024
Table 74. Bio-Rad Laboratories Recent Developments
Table 75. Fluidigm Corporation Information
Table 76. Fluidigm Description and Business Overview
Table 77. Fluidigm Transcriptomics Product
Table 78. Fluidigm Transcriptomics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Fluidigm Revenue Proportion of Transcriptomics by Product in 2024
Table 80. Fluidigm Revenue Proportion of Transcriptomics by Application in 2024
Table 81. Fluidigm Revenue Proportion of Transcriptomics by Geographic Area in 2024
Table 82. Fluidigm Recent Developments
Table 83. North America Transcriptomics Revenue by Country (2020-2025) & (US$ Million)
Table 84. North America Transcriptomics Revenue by Country (2026-2031) & (US$ Million)
Table 85. North America Transcriptomics Revenue by Type (2020-2025) & (US$ Million)
Table 86. North America Transcriptomics Revenue by Application (2020-2025) & (US$ Million)
Table 87. Asia-Pacific Transcriptomics Revenue by Region (2020-2025) & (US$ Million)
Table 88. Asia-Pacific Transcriptomics Revenue by Region (2026-2031) & (US$ Million)
Table 89. Asia-Pacific Transcriptomics Revenue by Type (2020-2025) & (US$ Million)
Table 90. Asia-Pacific Transcriptomics Revenue by Application (2020-2025) & (US$ Million)
Table 91. Europe Transcriptomics Revenue by Country (2020-2025) & (US$ Million)
Table 92. Europe Transcriptomics Revenue by Country (2026-2031) & (US$ Million)
Table 93. Europe Transcriptomics Revenue by Type (2020-2025) & (US$ Million)
Table 94. Europe Transcriptomics Revenue by Application (2020-2025) & (US$ Million)
Table 95. Latin America Transcriptomics Revenue by Country (2020-2025) & (US$ Million)
Table 96. Latin America Transcriptomics Revenue by Country (2026-2031) & (US$ Million)
Table 97. Latin America Transcriptomics Revenue by Type (2020-2025) & (US$ Million)
Table 98. Latin America Transcriptomics Revenue by Application (2020-2025) & (US$ Million)
Table 99. Middle East and Africa Transcriptomics Revenue by Country (2020-2025) & (US$ Million)
Table 100. Middle East and Africa Transcriptomics Revenue by Country (2026-2031) & (US$ Million)
Table 101. Middle East and Africa Transcriptomics Revenue by Type (2020-2025) & (US$ Million)
Table 102. Middle East and Africa Transcriptomics Revenue by Application (2020-2025) & (US$ Million)
Table 103. Transcriptomics Key Raw Materials, Industry Status and Trend
Table 104. Transcriptomics Key Raw Materials and Upstream Suppliers
Table 105. Transcriptomics Clients Status and Trend
Table 106. Transcriptomics Typical Clients
Table 107. Transcriptomics Distributors
Table 108. Transcriptomics Market Trends
Table 109. Transcriptomics Market Drivers
Table 110. Transcriptomics Market Challenges
Table 111. Transcriptomics Market Restraints
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Transcriptomics Product Picture
Figure 2. Global Transcriptomics Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Transcriptomics Revenue Market Share by Type in 2024 & 2031
Figure 4. PCR Product Picture
Figure 5. Microarray Product Picture
Figure 6. Sequencing Product Picture
Figure 7. Global Transcriptomics Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Transcriptomics Revenue Market Share by Application in 2024 & 2031
Figure 9. Pharmaceutical and Biotechnology
Figure 10. Academic Research and Government Institutes
Figure 11. Hospitals and Diagnostic Centers
Figure 12. Transcriptomics Report Years Considered
Figure 13. Global Transcriptomics Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Transcriptomics Market Size (2020-2031) & (US$ Million)
Figure 15. Global Transcriptomics Market Size Market Share by Region: 2024 Versus 2031
Figure 16. Global Transcriptomics Revenue Market Share by Region (2020-2031)
Figure 17. Global Transcriptomics Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Global Transcriptomics Revenue Market Share Forecast by Application (2020-2031)
Figure 19. PCR of Transcriptomics Revenue Market Share by Application, 2024 VS 2031
Figure 20. Microarray of Transcriptomics Revenue Market Share by Application, 2024 VS 2031
Figure 21. Sequencing of Transcriptomics Revenue Market Share by Application, 2024 VS 2031
Figure 22. Transcriptomics Revenue Share by Company (2024)
Figure 23. Transcriptomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. PCR Revenue Proportion by Company in 2024
Figure 25. Microarray Revenue Proportion by Company in 2024
Figure 26. Sequencing Revenue Proportion by Company in 2024
Figure 27. North America Transcriptomics Revenue 2020-2031 (US$ Million)
Figure 28. North America Transcriptomics Revenue Market Share by Type (2020-2025)
Figure 29. North America Transcriptomics Revenue Market Share by Application (2020-2025)
Figure 30. Asia-Pacific Transcriptomics Revenue 2020-2031 (US$ Million)
Figure 31. Asia-Pacific Transcriptomics Revenue Market Share by Region (2020-2031)
Figure 32. Asia-Pacific Transcriptomics Revenue Market Share by Type (2020-2025)
Figure 33. Asia-Pacific Transcriptomics Revenue Market Share by Application (2020-2025)
Figure 34. Europe Transcriptomics Revenue Growth Rate 2020-2031 (US$ Million)
Figure 35. Europe Transcriptomics Revenue Market Share by Country (2020-2031)
Figure 36. Europe Transcriptomics Revenue Market Share by Type (2020-2025)
Figure 37. Europe Transcriptomics Revenue Market Share by Application (2020-2025)
Figure 38. Latin America Transcriptomics Revenue Growth Rate 2020-2031 (US$ Million)
Figure 39. Latin America Transcriptomics Revenue Market Share by Country (2020-2031)
Figure 40. Latin America Transcriptomics Revenue Market Share by Type (2020-2025)
Figure 41. Latin America Transcriptomics Revenue Market Share by Application (2020-2025)
Figure 42. Middle East and Africa Transcriptomics Revenue Growth Rate 2020-2031 (US$ Million)
Figure 43. Middle East and Africa Transcriptomics Revenue Market Share by Country (2020-2031)
Figure 44. Middle East and Africa Transcriptomics Revenue Market Share by Type (2020-2025)
Figure 45. Middle East and Africa Transcriptomics Revenue Market Share by Application (2020-2025)
Figure 46. Transcriptomics Supply Chain (Upstream and Downstream Market)
Figure 47. Global Production Market Share of Transcriptomics Raw Materials by Region in 2024
Figure 48. Transcriptomics Distribution Channels
Figure 49. Global Transcriptomics Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 50. Global Transcriptomics Percentage 2020-2031: Online Sales VS Offline Sales
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232